Neurology:大龄Dravet综合征患者步态和运动异常进行性恶化

2022-05-24 Naomi MedSci原创

Dravet综合征是一种难治性、发育性和癫痫性脑病。近日,研究人员检查了患有DS的老年人的步态和运动表现,发现尽管患有DS的老年人的癫痫发作可能会减少,但其运动症状和步态随着年龄增长而逐渐恶化。

Dravet综合征(DS)是一种在出生第一年起病的难治性、发育性和癫痫性脑病(DeE)。超过80%的DS患者存在SCN1A基因的致病变异。SCN1A编码电压门控钠通道Nav1.1蛋白。水平降低或Nav1.1异常的结果之一。蛋白质是一种减少GABA能抑制,导致过度兴奋。然而,这种蛋白质也在其他组织中表达。因此,患者除了癫痫发作外,还存在认知发育减慢和步态障碍。

有趣的是,患有DS的成年人的父母和照顾者经常评论说,他们成年的孩子正在失去某些以前获得的技能,包括行走能力。为了对父母的观察提供客观的评估,近日,一项发表在Neurology上的研究针对一小群患者中进行了前瞻性评估,并在更大一组成年DS患者中进行了步态和帕金森症状的横断面评估。研究假设他们的步态和帕金森症特征会随着年龄的增长而恶化。

这项研究是一项前瞻性研究,6名患者(平均年龄32岁)在2014年和2019年通过统一帕金森氏病评定量表(MUPDRS)的修订版进行了检查。MUPDRS评分被分配给步态、静息性震颤、面部表情、椅子引起的姿势和身体运动迟缓。横断面手臂包括2014年没有评估的患者的mUPDRS测试,以及仪器性步态分析(IGA)。这些横断面测试是在2019-2020年期间进行的。IGA是使用ProtoKinetics软件进行的,步态垫上安装了传感器和两个摄像头,可以捕捉矢状面和冠状面。对17例DS患者进行免疫球蛋白A检查,平均年龄31岁,对照组81例,平均年龄62岁。对IGA和MUPDRS数据进行回归分析。

  • 在五年的前瞻性评估中,六名参与者中有五名经历了帕金森症状的恶化,包括步态。
  • 两名患者(47岁和51岁)最初可以行走,5年后不能行走。
  • 对一大群成年人的MUPDRS的横断面分析显示,坐在椅子上(p=0.04)、身体运动迟缓(p=0.01)和步态(p=0.0003)的较差得分与年龄呈正相关。
  • IGA横断臂显示,所有17名成年DS患者在所有测试领域都有异常步态参数。
  • 这组患者的表现比健康和老年对照组更差。

尽管患有DS的老年人的癫痫发作可能会减少,但这项前瞻性的横断面研究表明,他们的运动症状和步态随着年龄的增长而逐渐恶化。

文献来源:Selvarajah A, Gorodetsky C, Marques P, et al. Progressive Worsening of Gait and Motor Abnormalities in Older Adults With Dravet Syndrome [published online ahead of print, 2022 Apr 13]. Neurology. 2022;10.1212/WNL.0000000000200341. doi:10.1212/WNL.0000000000200341

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1742009, encodeId=60411e4200951, content=<a href='/topic/show?id=5681632e84e' target=_blank style='color:#2F92EE;'>#步态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63278, encryptionId=5681632e84e, topicName=步态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f034999566, createdName=xxxx1061, createdTime=Sun Dec 18 15:27:50 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976663, encodeId=664e19e6663a5, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Jan 22 04:27:50 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001817, encodeId=455d200181e50, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Feb 19 21:27:50 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813912, encodeId=c1b51813912b3, content=<a href='/topic/show?id=101f9416466' target=_blank style='color:#2F92EE;'>#运动异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94164, encryptionId=101f9416466, topicName=运动异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Mon Oct 03 04:27:50 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222102, encodeId=81f9122210296, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue May 24 15:44:21 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6238, encryptionId=73556238a1, topicName=Dravet综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432321, encodeId=38941432321f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=)]
    2022-12-18 xxxx1061
  2. [GetPortalCommentsPageByObjectIdResponse(id=1742009, encodeId=60411e4200951, content=<a href='/topic/show?id=5681632e84e' target=_blank style='color:#2F92EE;'>#步态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63278, encryptionId=5681632e84e, topicName=步态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f034999566, createdName=xxxx1061, createdTime=Sun Dec 18 15:27:50 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976663, encodeId=664e19e6663a5, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Jan 22 04:27:50 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001817, encodeId=455d200181e50, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Feb 19 21:27:50 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813912, encodeId=c1b51813912b3, content=<a href='/topic/show?id=101f9416466' target=_blank style='color:#2F92EE;'>#运动异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94164, encryptionId=101f9416466, topicName=运动异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Mon Oct 03 04:27:50 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222102, encodeId=81f9122210296, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue May 24 15:44:21 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6238, encryptionId=73556238a1, topicName=Dravet综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432321, encodeId=38941432321f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1742009, encodeId=60411e4200951, content=<a href='/topic/show?id=5681632e84e' target=_blank style='color:#2F92EE;'>#步态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63278, encryptionId=5681632e84e, topicName=步态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f034999566, createdName=xxxx1061, createdTime=Sun Dec 18 15:27:50 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976663, encodeId=664e19e6663a5, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Jan 22 04:27:50 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001817, encodeId=455d200181e50, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Feb 19 21:27:50 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813912, encodeId=c1b51813912b3, content=<a href='/topic/show?id=101f9416466' target=_blank style='color:#2F92EE;'>#运动异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94164, encryptionId=101f9416466, topicName=运动异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Mon Oct 03 04:27:50 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222102, encodeId=81f9122210296, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue May 24 15:44:21 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6238, encryptionId=73556238a1, topicName=Dravet综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432321, encodeId=38941432321f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=)]
    2023-02-19 yinhl1978
  4. [GetPortalCommentsPageByObjectIdResponse(id=1742009, encodeId=60411e4200951, content=<a href='/topic/show?id=5681632e84e' target=_blank style='color:#2F92EE;'>#步态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63278, encryptionId=5681632e84e, topicName=步态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f034999566, createdName=xxxx1061, createdTime=Sun Dec 18 15:27:50 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976663, encodeId=664e19e6663a5, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Jan 22 04:27:50 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001817, encodeId=455d200181e50, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Feb 19 21:27:50 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813912, encodeId=c1b51813912b3, content=<a href='/topic/show?id=101f9416466' target=_blank style='color:#2F92EE;'>#运动异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94164, encryptionId=101f9416466, topicName=运动异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Mon Oct 03 04:27:50 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222102, encodeId=81f9122210296, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue May 24 15:44:21 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6238, encryptionId=73556238a1, topicName=Dravet综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432321, encodeId=38941432321f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=)]
    2022-10-03 gous
  5. [GetPortalCommentsPageByObjectIdResponse(id=1742009, encodeId=60411e4200951, content=<a href='/topic/show?id=5681632e84e' target=_blank style='color:#2F92EE;'>#步态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63278, encryptionId=5681632e84e, topicName=步态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f034999566, createdName=xxxx1061, createdTime=Sun Dec 18 15:27:50 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976663, encodeId=664e19e6663a5, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Jan 22 04:27:50 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001817, encodeId=455d200181e50, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Feb 19 21:27:50 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813912, encodeId=c1b51813912b3, content=<a href='/topic/show?id=101f9416466' target=_blank style='color:#2F92EE;'>#运动异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94164, encryptionId=101f9416466, topicName=运动异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Mon Oct 03 04:27:50 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222102, encodeId=81f9122210296, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue May 24 15:44:21 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6238, encryptionId=73556238a1, topicName=Dravet综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432321, encodeId=38941432321f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=)]
    2022-05-24 屋顶瞄爱赏月

    签到学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1742009, encodeId=60411e4200951, content=<a href='/topic/show?id=5681632e84e' target=_blank style='color:#2F92EE;'>#步态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63278, encryptionId=5681632e84e, topicName=步态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f034999566, createdName=xxxx1061, createdTime=Sun Dec 18 15:27:50 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976663, encodeId=664e19e6663a5, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Jan 22 04:27:50 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001817, encodeId=455d200181e50, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Feb 19 21:27:50 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813912, encodeId=c1b51813912b3, content=<a href='/topic/show?id=101f9416466' target=_blank style='color:#2F92EE;'>#运动异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94164, encryptionId=101f9416466, topicName=运动异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Mon Oct 03 04:27:50 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222102, encodeId=81f9122210296, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue May 24 15:44:21 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6238, encryptionId=73556238a1, topicName=Dravet综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432321, encodeId=38941432321f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1742009, encodeId=60411e4200951, content=<a href='/topic/show?id=5681632e84e' target=_blank style='color:#2F92EE;'>#步态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63278, encryptionId=5681632e84e, topicName=步态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f034999566, createdName=xxxx1061, createdTime=Sun Dec 18 15:27:50 CST 2022, time=2022-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976663, encodeId=664e19e6663a5, content=<a href='/topic/show?id=acd4943925f' target=_blank style='color:#2F92EE;'>#进行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94392, encryptionId=acd4943925f, topicName=进行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=869698, createdName=ligang4439, createdTime=Sun Jan 22 04:27:50 CST 2023, time=2023-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001817, encodeId=455d200181e50, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Feb 19 21:27:50 CST 2023, time=2023-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1813912, encodeId=c1b51813912b3, content=<a href='/topic/show?id=101f9416466' target=_blank style='color:#2F92EE;'>#运动异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94164, encryptionId=101f9416466, topicName=运动异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Mon Oct 03 04:27:50 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222102, encodeId=81f9122210296, content=签到学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Tue May 24 15:44:21 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6238, encryptionId=73556238a1, topicName=Dravet综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7460166, createdName=zhang92560, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432321, encodeId=38941432321f6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue May 24 06:27:50 CST 2022, time=2022-05-24, status=1, ipAttribution=)]

相关资讯

Neurology:活体人脑可见的Edinger梳征和Wilson铅笔征

“直接”和“间接”通路在运动障碍性疾病的病理生理学中发挥重要的作用。

Neurology:不安腿综合征与运动障碍

PD患者的RLS患病率高于预期

JNNP:患有嗜睡症和活动性运动障碍的儿童中常见有神经元表面抗体综合征

1型嗜睡症(NT1)是一种疑似自身免疫性病因的慢性睡眠障碍。在儿童群体中,介绍了一种复杂的运动障碍,其临床症状是典型的摔倒和其他低张(“阴性”)运动特征,也有“主动

Lancet Neurol:Pridopidine用于亨廷顿病患者II期疗效不显著

研究认为,Pridopidine不能改善亨廷顿病患者UHDRS-TMS评分

深度解析:周围神经病变的诊断,看这一篇就够了!

周围神经病变是周围神经受损的结果,由各种病因引起的周围神经系统结构或功能损害的疾病总称,通常会引起四肢无力、麻木和疼痛,它也会影响身体的其他部位。

Stroke:上肢卒中后运动障碍的结构和功能相关性

由此可见,定量神经生理学指标的实施,例如静息运动阈值在神经康复试验中可以考虑将其作为损伤的替代指标。

拓展阅读

FDA 授予 NT102治疗Dravet 综合征的孤儿药称号

Dravet 综合征是一种罕见的儿童期综合征,每 15,700 名在美国出生的婴儿中就有 1 人受到影响,其特征是脑病和癫痫。很难诊断,因为许多症状在孩子出生后的第一年并不明显。

Zogenix癫痫药物Fintepla的营销申请遭到FDA拒绝

美国食品和药物管理局(FDA)拒绝全面审查Zogenix的癫痫发作药物Fintepla(ZX008,低剂量芬氟拉明)的营销申请。

CNS 2015:大麻不仅对癫痫疗效好,还有更多奇效

近期有研究者提出,对儿童难治性癫痫使用包含纯大麻二酚的临床实验产品(Epidiolex) ,在未来可以得到更多的积极的成果。研究结果显示该药物可以家少3个月婴儿38%的癫痫发生,减少6个月婴儿31%的癫痫发生。该研究纳入了药物治疗无效的癫痫患者,包括Dravet综合症、Lennox-Gastaut综合症、早发性癫痫脑病的混合类型、原因不明的难治性癫痫、结构性损伤患者。参与者服用大麻二酚 (CBD)

2022 NICE科技评估指南:芬氟拉明Fenfluramine用于治疗与 Dravet 综合征相关的癫痫发作 [TA808]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-07-08